계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
QurAlis
company
About
QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for ALS.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $42M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Dec 12, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS .
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$42M
QurAlis has raised a total of
$42M
in funding over 2 rounds. Their latest funding was raised on
May 13, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 13, 2020 | Series A | $42M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
QurAlis is funded by 1 investors.
Sanford Biosciences
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
